Gordon L. Sussman

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results”.

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.11.017

N/A

0DataRank · unranked

62 citations

Rémi Gagnon, Gordon L. Sussman, Dareen Siri, Roxanne C. Oriel, Terri F. Brown‐Whitehorn +31 more

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities

Journal of Allergy and Clinical Immunology Global(2022)10.1016/j.jacig.2022.07.009

N/A

0DataRank · unranked

9 citations

Lars Lange, Kirsten Beyer, David M. Fleischer, Lara S. Ford, Gordon L. Sussman +10 more

Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials

Annals of Allergy Asthma & Immunology(2022)10.1016/j.anai.2022.07.033

N/A

0DataRank · unranked

13 citations

Alan B. Goldsobel, Aikaterini Anagnostou, Kirsten Beyer, Thomas B. Casale, A. Deschildre +70 more

Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

UNC Libraries(2025)10.17615/t79e-pf69

N/A

0DataRank · unranked

3 citations

Tara F. Carr, Antonella Muraro, Bruce J. Lanser, Jay M. Portnoy, Aikaterini Anagnostou +57 more